Immunodeficiency 32b C4751209
A rare primary immunodeficiency causing increased susceptibility to infections due to impaired immune defenses. Usually presents in childhood. Treatment includes infection prevention and immune system support.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Opportunistic infections
Generalized symptoms
(immunologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Recurrent bacterial infections
(immunologic)Chronic fatigue
(immunologic)Granuloma formation
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Intravenous Immunoglobulin Therapy
Regular infusion of pooled human immunoglobulin to provide broad-spectrum antibody coverage in patients with specific antibody deficiency. Dosing individualized based on clinical response and trough levels.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Infection Surveillance Program
Proactive monitoring for early signs of infection through regular clinical assessments and laboratory markers. Rapid intervention when infections are detected reduces complications and hospitalization needs.
Additional treatment options
Protein-Calorie Optimization
Enhanced intake of high-quality protein and adequate calories to support humoral immune system function and recovery from infections. Assessment for malabsorption and adjusted texture as needed.
dietaryChronic Illness Counseling
Psychological support addressing anxiety, depression, and quality of life concerns associated with living with a chronic immunodeficiency. Coping strategies and stress reduction techniques complement medical management.
psychologicalFunctional Strength Training
Supervised exercise program designed to maintain muscle mass and functional capacity, which supports overall immune competence and reduces infection-related deconditioning. Graduated intensity based on health status.
physical_therapyWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Immunodeficiency 32b C4751209?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Immunodeficiency 32b C4751209. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy